TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
XCUR

Exicure Inc

Healthcare · Biotechnology

1.30$ +2.4% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XCUR
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
97.9% 97.4% 95.3% 96.2% 97.8% 85.9% 67.3% 43.1% 17.5% 90.8% 32.9%
95.5% 95.4% 88.9% 91.3% 42.0% 33.1% 53.4% 36.8% 7.0% 83.1% 26.7%
95.5% 95.4% 88.9% 91.3% 96.1% 81.7% 60.3% 36.8% 7.0% 83.1% 26.7%
1.5% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.5% 2.2% 3.5% 0.4%
0.0% 2.2% 0.6% 3.0% 2.2% -2.2%
2.0% 2.4% 4.5% 3.7% 2.1% 4.1% 18.3% 42.0%
0.0% 31.3%
26.9%
7.1% 88.1% 31.1% 27.1% 29.9% 38.8% 82.7% 36.0% 73.8% 55.0% 72.0%
6.8% 59.1% 11.6% 7.1% 27.0% 13.7% 52.5% 7.0% 21.7% 20.4% 27.7%
5.9% 16.7% 4.6% 0.2% 11.3% 2.3% 5.4% 4.8% 1.3%
3.2% 2.5% 3.6% 1.7% 1.6% 1.9% 5.3% 1.5% 14.1% 6.8% 12.0%
21.6% 16.7% 17.1% 16.5%
92.9% 11.9% 68.9% 72.9% 70.1% 61.2% 17.3% 64.0% 26.2% 45.0% 28.0%
-28.9% -109.9% -116.0% -191.2% -70.5% -105.5% -262.2% -740.1% -1,637.0% -1,323.5% -1,454.4%
6.7% 6.4% 4.5% 4.8% 1.7% 2.9% 4.6% 19.8% 69.2% 40.5% 44.8%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?